Multicenter, Prospective, Open Label Trial, Uncontrolled to Determine the Efficacy and Safety of Depocyt for the Treatment of CNS Relapse in Adult Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2012
At a glance
- Drugs Cytarabine (Primary)
- Indications Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 16 Sep 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 16 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2009 Planned end date changed from Mar 2008 to Dec 2009 as reported by ClinicalTrials.gov.